Results of the Uristat test (Shield Diagnostics Ltd.), a novel enzyme-linked immunosorbent assay (ELISA) for detection of urine antibodies to seven common bacterial pathogens, were compared with results of urine culture, urinalysis, and clinical history to determine the usefulness of Uristat in the diagnosis of urinary tract infections (UTIs). Midstream, catheterized, and indwelling catheter urine specimens sent to the laboratory for culture were included in the study. Quantitative cultures were performed on both 5% sheep blood agar and eosin-methylene blue agar. Uristat ELISAs were performed according to the manufacturer's instructions. By using a Bacillus subtilis bioassay technique, antibacterial activity was detected in the urine of 236 (22.2%) of 1,061 patients. Probable, possible, or asymptomatic UTIs were diagnosed for 258 (24.3%) of the 1,061 patients. Of those infections, 219 (84.9%o) were caused by bacterial species whose antibodies were detectable by Uristat. Uristat's sensitivity and specificity were 76.7 and 56.0%o, respectively. Uristat's predictive values of positive and negative results were 31.2 and 90.2%, respectively. Further development of the Uristat test is necessary before it can be of assistance in the diagnosis of UTIs.
Clinical diagnosis of a urinary tract infection (UTI) is frequently difficult, particularly for women with frequency of urination and dysuria (29, 33, 39) . In addition to a UTI, other causes of these symptoms include vulvovaginitis (with or without urethritis), genitourinary trauma, urethral irritants, and allergic reactions (9, 16) . The diagnosis of a UTI can be made with greater accuracy in some patient populations if laboratory tests, including culture and microscopic determination of pyuria, hematuria, and bacteriuria, are performed (29, 33) . However, none of these assays consistently provides a high level of both sensitivity and specificity. Culture results may be falsely positive because of contamination at the time of specimen collection from organisms in the distal urethra, vagina, and labial or periurethral skin (37) . Culture results may also be falsely negative, or colony counts of isolates may be significantly reduced, because of factors including, but not limited to, the type or stage of disease, the use of antibiotics, the hydration of the patient, the specimen collection and transport methods used, and the type of pathogen involved (14, 16, 45) . Measuring pyuria is a relatively simple, readily available means of establishing the presence of tissue invasion or the host's response to infection (37) . Pyuria is a usually highly sensitive but sometimes nonspecific indicator of UTI (10, 11, 16, 18, 22, 29, 30, 32, 33, (37) (38) (39) 44) . In contrast, microscopic determinations of hematuria and bacteriuria are highly specific for UTI but may (10) or may not (30, 44) (41) . Normal (uninfected) patients usually have no urine antibodies or very low levels of antibodies (7, 8, 12, 22, 28, 31, 34, 43) . Antibodies detectable in the urine include secretory immunoglobulin A (IgA), IgA, and IgG (1, 4, 5, 7, 8, 12, 22, 28, 34, 40, 43) but usually do not include IgM (8, 12, 22, 34, 40) . Peak urine antibody levels are usually reached within 10 days after the onset of infection during the period of symptoms (1, 4, 5) . The levels may decline in many (but not all) patients, especially those with pyelonephritis, shortly after the cultures become negative (1, 5, 31 (15) . Counts of .100 CFU (from eosin-methylene blue agar) or > 1,000 CFU (from sheep blood agar) of known urinary tract pathogens per ml of urine were considered potentially significant by the laboratory and were reported (14, 25) .
Determination of antibacterial activity in urine (26) . A Mueller-Hinton agar plate was inoculated with 108 CFU of Bacillus subtilis ATCC 6633 per ml. After the inoculum had dried, 20 ,ul of mixed urine was added to a blank 6-mmdiameter paper disc on the plate, and the culture was incubated for 18 to 24 h at 35°C. Any zone of growth inhibition around the disc indicated the presence of antibacterial activity in the urine.
Uristat ELISA detection of urine antibodies. The ELISA was performed as described by the manufacturer, except that all specimens were tested in duplicate to check for reproducibility of results. From each urine specimen, 100 ,ul was added to each of two Uristat test wells located on two different test strips. After 100 pul of wash buffer (as a blank), low-positive controls, and high-positive controls was pipetted into the respective wells, the test strips were incubated for 30 min at 25°C. The wells were decanted and washed three times with wash buffer, and then 100 [lI of conjugate was added to each well. After incubation for another 30 min at 25°C, the wells were washed again three times, and 100 ,ul of substrate was added to each well. After incubation of the strips for 15 min at 25°C, 100 ,ul of stop solution was added to the wells and the optical density of each well was determined at 554 nm. A patient's result was considered positive if the ratio of the result for the first of two wells tested per specimen to the result for the low-positive control was >1.0.
Urinalysis. Urine specimens submitted for culture were analyzed by standard methods for the presence of erythrocytcs, protein, hemoglobin, and bacteria. Pyuria was determined by counting the number of leukocytes per high-power (magnification, x400) field from a centrifuged urine specimen. A result of .4 leukocytes per high-power field was considered positive (39) and appeared to offer, on the basis of our experience and that of previous reports (19, 39) , satisfactory clinical correlation.
Diagnosis of UTIs. The clinical history of each patient was reviewed by a physician participating in this study. Signs or symptoms including dysuria, urgency or frequency of urination, nocturia, flank pain, fever, hematuria, and a foul odor were all documented. In addition, a history of recent sexually transmitted disease or UTI, as well as recent administration of antibiotics (within 6 days of urine collection) or immunosuppressive drugs, was noted. The physicians' reason for ordering urine cultures was documented as either a routine workup (usually on hospital admission), evidence of sepsis (fever), or symptoms of a UTI. The diagnosis of UTI was based on previously determined criteria (25, 37) . Patients were concluded either to be uninfected or to have a probable, possible, or asymptomatic infection. Patients considered to be uninfected had no signs or symptoms and < 100,000 CFU/ml of urine or were colonized with > 100,000 CFU/ml of urine but had no symptoms and no pyuria (37) . Patients were considered to have a probable infection if they had at least one symptom and a culture containing a probable uropathogen at .100 CFU/ml. Those with a possible infection also had at least one symptom and a positive culture at >100 CFU/ml, but an alternative diagnosis could not be ruled out. Patients with asymptomatic infections had no specific symptoms but had both pyuria and a urine culture with >100,000 CFU of a uropathogen per ml.
Physicians determining the clinical histories of patients were unaware of laboratory results from the most recent urine specimens from those patients. In addition, technologists performed either the Uristat ELISAs, culture, or urinalysis and were unaware of any other laboratory results from specimens that they were testing. The Z test for differences in proportions for independent samples was used for statistical analysis of results (2) . Directional (one-tail) results were considered to be significant if the probability of the null hypothesis was 0.05 or less. Confidence intervals around the single-point proportion estimates were calculated by equation 1 (20) .
Falsely negative results of the Uristat test could be expected to occur because of many factors other than test insensitivity. These factors include decreased synthesis or increased degradation of antibodies in some patients (4, 20, 28, 34) , variations in water diuresis (4, 21) , antibiotic therapy (28), low levels of antibodies in infants younger than 1 year of age (1, 4, 8, 12) , and the presence of either bacteria (1, 8) or soluble bacterial antigen (31) in the urine, resulting in absorption and a reduction in free detectable antibodies. Falsely positive Uristat results might also be expected for reasons other than lack of test specificity. Such reasons include leakage of serum antibodies through inflammed urinary tract mucosae (22, 28) , prior immunologic stimulation by either normal intestinal flora or infection at another body site (28) , prolonged elevation of antibody levels from previous UTIs (28) , and recent insertion of catheters without bacteriuria (21) . Uristat results may also appear falsely positive but may come from patients with false-negative cultures. Such situations may occur with patients on antibiotics (14, 20, 30, 38, 45) or those whose urine has inherent antibacterial activity (13, 14, 23, 24) .
Recent antibiotic use was indicated by patient history or bioassay for a high number (282 [27%]) of the patients whose urine specimens were submitted for culture in the current study. Our results showed that 80% of patients with a recent history of treatment with antimicrobial agents had positive bioassay results, while 79% of patients with positive bioassay results had a recent history of antibiotic administration. These results are very similar to those in a previous report (3) . In the current study, however, the presence of antibacterial activity had no significant influence on the sensitivity of Uristat. Antibacterial activity in urine specimens may be due to factors other than antibiotic usage, including the presence of detergents (30) , low pH (23, 24) , high concentrations of urea (13, 23) and ammonium ions (13) , increased osmolality (13, 23, 24) , and the presence of prostatic fluid (36) .
In summary, careful documentation of symptoms, physical findings, and laboratory results are essential for the diagnosis and management of UTIs in many types of patients (33) . The Uristat test, in the form in which it is currently available, did not provide either sensitivity or specificity which could assist in the diagnosis of such infections. The large number of factors that could contribute to falsepositive or false-negative results for the presence of urinary tract antibodies raises the question of whether the Uristat test or any similar product could be expected to provide a clinically useful level of sensitivity or specificity.
